ARTICLE | Clinical News
Zalviso regulatory update
July 14, 2014 7:00 AM UTC
Partner Gruenenthal Group (Aachen, Germany) submitted an MAA to EMA for Zalviso to manage moderate to severe acute pain in adults in a medically supervised environment. The submission triggered a $5 ...